Atzeni F, Sallì S, Benucci M, Di Franco M, Alciati A, Sarzi-Puttini P
Rheumatology Unit, L. Sacco University Hospital of Milan, Italy.
Reumatismo. 2012 Sep 28;64(4):286-92. doi: 10.4081/reumatismo.2012.286.
Fibromyalgia (FM) is a chronic pain syndrome that affects at least 2% of the adult population. It is characterised by widespread pain, fatigue, sleep alterations and distress, and emerging evidence suggests a central nervous system (CNS) malfunction that increases pain transmission and perception. FM is often associated with other diseases that act as confounding and aggravating factors, such as rheumatoid arthritis (RA), spondyloarthritides (SpA), osteoarthritis (OA) and thyroid disease. Mechanism-based FM management should consider both peripheral and central pain, including effects due to cerebral input and that come from the descending inhibitory pathways. Rheumatologists should be able to distinguish primary and secondary FM, and need new guidelines and instruments to avoid making mistakes, bearing in mind that the diffuse pain of arthritides compromises the patients' quality of life.
纤维肌痛(FM)是一种慢性疼痛综合征,影响至少2%的成年人口。其特征为广泛疼痛、疲劳、睡眠改变和痛苦,新出现的证据表明存在中枢神经系统(CNS)功能障碍,会增加疼痛传递和感知。FM常与其他作为混杂和加重因素的疾病相关,如类风湿关节炎(RA)、脊柱关节炎(SpA)、骨关节炎(OA)和甲状腺疾病。基于机制的FM管理应同时考虑外周和中枢性疼痛,包括大脑输入及下行抑制通路产生的影响。风湿病学家应能够区分原发性和继发性FM,并且需要新的指南和工具以避免犯错,同时要记住关节炎的弥漫性疼痛会损害患者的生活质量。